SAM
MXCT icon

Silvercrest Asset Management’s MaxCyte MXCT Stock Holding History

Silvercrest Asset Management’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,074,631
Closed -$2.34M – 859
2025
Q2 		$2.34M Hold
1,074,631
– – 0.02% 531
2025
Q1 		$2.93M Sell
1,074,631
-6,206
-0.6% -$24.5K 0.02% 484
2024
Q4 		$4.5M Sell
1,080,837
-10,653
-1% -$40.3K 0.03% 437
2024
Q3 		$4.25M Buy
1,091,490
+383,327
+54% +$1.62M 0.03% 403
2024
Q2 		$2.78M Buy
708,163
+9,074
+1% +$39K 0.02% 474
2024
Q1 		$2.93M Buy
699,089
+30,209
+5% +$142K 0.02% 459
2023
Q4 		$3.14M Sell
668,880
-591,743
-47% -$2.3M 0.02% 441
2023
Q3 		$3.93M Sell
1,260,623
-3,426
-0.3% -$13.8K 0.03% 399
2023
Q2 		$5.8M Buy
1,264,049
+173,747
+16% +$798K 0.04% 340
2023
Q1 		$5.4M Buy
1,090,302
+144,062
+15% +$709K 0.04% 333
2022
Q4 		$5.17M Sell
946,240
-8,910
-0.9% -$54.6K 0.04% 340
2022
Q3 		$6.21M Sell
955,150
-25,881
-3% -$144K 0.05% 291
2022
Q2 		$4.64M Buy
981,031
+332,351
+51% +$1.64M 0.04% 355
2022
Q1 		$4.53M Buy
+648,680
New +$4.43M 0.03% 390

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.05B AUM 22.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
AIM
AXA Investment Managers Puteaux, France $37.1B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Silvercrest Asset Management's MXCT Position: Q3 2025 in Review

Silvercrest Asset Management sold out of MaxCyte (MXCT) in Q3 2025, closing a stake of 1,074,631 shares — an estimated $2.34M sold.

Silvercrest Asset Management first reported a position in MXCT in Q1 2022 and held it in 14 quarters. The position peaked at $6.21M in Q3 2022. 112 funds tracked by Wall St. Rank hold MXCT as of Q3 2025.

  • Silvercrest Asset Management reported no remaining MaxCyte position as of Q3 2025 after selling out during the quarter.
  • Silvercrest Asset Management sold 1,074,631 MaxCyte shares in Q3 2025, an estimated $2.34M.
  • Silvercrest Asset Management first reported a position in MaxCyte in Q1 2022 and held it in 14 quarters.
  • Silvercrest Asset Management's MaxCyte position peaked at $6.21M in Q3 2022.
  • 112 funds tracked by Wall St. Rank held MaxCyte as of Q3 2025.

Based on Silvercrest Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.